<DOC>
	<DOCNO>NCT02944890</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy Paclitaxel drug elute balloon ( RESTORE DEB , 3μg/mm2 balloon surface area ) success intervention treatment maintain vessel unobstructed treatment coronary in-stent restenosis compare product category ( SeQuent® Please ) .</brief_summary>
	<brief_title>Compare Efficacy Safety RESTORE DEB SeQuent® Please Chinese Patient With Coronary In-stent Restenosis</brief_title>
	<detailed_description />
	<mesh_term>Coronary Restenosis</mesh_term>
	<criteria>Related patient : 1 . Age ≥18 year old 2 . Patients agree receive followup month1 , 6 , 9 12 , receive angiography month9 . 3 . Patients able understand objective study mentally language . Patients indicate sufficient compliance study , acknowledge risk benefit sign informed consent form . 4 . Patients stable angina pectoris , unstable angina pectoris , old myocardial infarction , prove asymptomatic regional myocardial ischemia 5 . Patients suitable receive coronary revascularization type ( include balloon angioplasty , stent implantation coronary artery bypass graft ) Related disease : 6 . Restenosis Mehran type IIII stent implantation ( include bare metal stent , stent inert coating , stent active coating ) first time 7 . Diameter stent restenosis 2.54.0mm ( include ) . Length stenosis lesion 26mm , diameter stenosis operation ≥70 % , ≥50 % evidence ischemia . 8 . One subject allow 2 target lesion , 2 Paclitaxel drug balloon dilation . 9 . The distance lesion require intervention target lesion must &gt; 10mm . Related patient : 1 . Pregnant lactate woman , woman plan get pregnant within 12 month refuse take effective contraceptive . 2 . The patient participate clinical trial reach primary endpoint . 3 . The patient life expectancy le 12 month , would difficult finish followup within 12 month . 4 . The patient cerebral stroke within 6 month include , history peptic ulcer gastrointestinal bleeding past 6 month , patient bleed tendency accord investigator . 5 . Patients history leukopenia ( white blood cell count &lt; 3×109/L 3 day ) neutropenia ( ANC &lt; 1000/mm3 3 day ) thrombocytopenia ( platelet &lt; 100,000/mm3 ) 6 . Patients forbidden use anticoagulation agent antiplatelet drug , unable tolerate Aspirin Clopidogrel 7 . Patients renal insufficiency ( eGFR &lt; 30mL/min ) 8 . Patients know allergic Paclitaxel 9 . Patients myocardial infarction within 1 week include 10 . Patients heart transplantation 11 . Patients severe congestive heart failure NYHA grade IV heart failure 12 . Patients severe valvular heart disease 13 . Patients unsuitable study accord investigator due reason Related disease : 14 . Patients evidence extensive thrombosis target vessel intervention 15 . Patients total occlusion indicate TIMI 0 blood flow target lesion ( Mehran type IV stenosis ) 16 . Patients multiple lesion ( ≥3 ) require percutaneous coronary intervention treatment artery 17 . Patients lesion require intervention treatment 3 vessel 18 . The diameter branch lesion target lesion ≥2.5mm 19 . Patients already treat CABG instent restenosis 20 . LM lesions Ostial lesion within 5mm root aorta</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>